Guatemala — Fruit and Fruit Products — Fruit-Other

← back to leaderboard

Guatemala received 39 FDA import refusals in Fruit-Other, part of Fruit and Fruit Products between 2023-Q3 and 2026-Q2. Volume peaked at 31 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are mfr insan and mfr inj. No trade baseline is published for this commodity from Guatemala, so no per-$1B rate is shown here.

Of these, 38 were hazard refusals and 1 were paperwork refusals.

Exporting from Guatemala? Get an email when shipments from Guatemala are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q3 2023-Q3: 0 0 2023-Q4 2023-Q4: 0 0 2024-Q1 2024-Q1: 0 1 2024-Q2 2024-Q2: 1 1 2024-Q3 2024-Q3: 1 1 2024-Q4 2024-Q4: 1 0 2025-Q1 2025-Q1: 0 0 2025-Q2 2025-Q2: 0 1 2025-Q3 2025-Q3: 1 1 2025-Q4 2025-Q4: 1 3 2026-Q1 2026-Q1: 3 31 2026-Q2 2026-Q2: 31

Recent rejections